Non-exclusive discount agreement for Morphine (FTA + HKP + SMT), ATC N02AA01
Notice title: Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Morphin (ausschl. in der Dafo. FTA + HKP + SMT), ATC N02AA01 f. d. Z. 01.01.27-31.12.28, zzgl V.-Option 1x12M
Non-exclusive discount agreement for the active ingredient Morphine (dosage forms FTA + HKP + SMT), ATC N02AA01: Conclusion of a framework agreement for pharmaceutical companies under equal conditions. Duration from 01.01.2027 to 31.12.2028, with a 1x12 month extension option. Required documents include an offer letter, acceptance of DAK-Gesundheit's contractual terms and discounts, and completed Annexes 1 and 2 (list of medicines). Submission of documents via email to openhouse@dak.de; Annex 2 as an Excel file. Participation by 01.01.2027 requires submission by the 5th of the preceding month; later entries on the 1st or 15th of the following month require submission by the 5th of the preceding month.
Never miss a tender again
We send you 3 current matches that fit your company.
Tender documents
- Portal — LOT-0001NON-RESTRICTED-DOCUMENT
- TED HTML — 797463-2026HTML
- TED PDF — 797463-2026PDF
- TED XML — 797463-2026XML
Unlock documents for free
Enter your email address. If you confirm, we will also send you 3 similar tenders.